Clinical trial · Interventional
Screening Tools to Predict Treatment Outcome in Older Cancer Patients Who Are Undergoing Treatment
Impact of Frailty in Senior Cancer Patients: Feasibility and Value of Screening Tools and Geriatric Intervention and Predictive Value of a Screening Tool in Relation to Treatment Outcome
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Questionnaires that measure how well older patients think, learn, remember, and make judgments and carry out daily activities may improve the ability to plan treatment for patients with cancer. PURPOSE: This clinical trial is studying testing for fitness to undergo chemotherapy to see how well it works in predicting treatment outcomes in older patients with cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Unspecified Adult Solid Tumor, Protocol Specific | Adult Solid Neoplasm | ALIAS | 0.85 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| cognitive assessment | Procedure | — | UNRESOLVED |
| examination | Procedure | — | UNRESOLVED |
| management of therapy complications | Procedure | — | UNRESOLVED |
| questionnaire administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (3)
- measure
- Feasibility of applying screening tools (Groningen Frailty Indicator [GFI] and G8) in older patients with cancer
- measure
- Comparison of the screening tools (GFI and G8) with a comprehensive geriatric assessment (CGA)
- measure
- Predictive value of the screening tool to undergo standard anticancer treatment in terms of toxicity according to the NCI-CTC
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 65 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Histologically or cytologically confirmed cancer * Undergoing out-patient care * Planning to undergo primary chemotherapeutic treatment or treatment with targeted agents for curative or palliative intent * No symptomatic brain metastases PATIENT CHARACTERISTICS: * Able to understand the Flemish language, give informed consent, and be followed at the investigational site * Must be considered eligible for trial participation by the Investigator * No severe known dementia * No pre-existing major neurological or psychiatric problems * No refusal of the standard anticancer strategy as defined by the service instruction book PRIOR CONCURRENT THERAPY: * See Disease Characteristics
References
Publications (0)
Data not yet available